Horizon Therapeutics Public Ltd Co Return On Equity in % from 2012 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Return On Equity history and growth rate from 2012 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Return On Equity for the quarter ending June 30, 2023 was 8.54 %, a 47.3% decline year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Return On Equity for 2022 was 10.5 %, a 16.3% decline from 2021.
  • Horizon Therapeutics Public Ltd Co annual Return On Equity for 2021 was 12.5 %, a 0.48% decline from 2020.
  • Horizon Therapeutics Public Ltd Co annual Return On Equity for 2020 was 12.6 %, a 62.8% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

Horizon Therapeutics Public Ltd Co Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2023 8.54 -7.66 -47.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 7.38 -11.8 -61.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 10.5 -2.04 -16.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 11.8 -1.66 -12.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 16.2 +3.04 +23.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 19.1 +11.2 +140% Jan 1, 2022 Mar 31, 2022
Q4 2021 12.5 -0.06 -0.48% Oct 1, 2021 Dec 31, 2021
Q3 2021 13.5 -16.6 -55.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 13.2 -11.8 -47.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 7.98 -23.8 -74.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 12.6 -21.3 -62.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 30.1 +24.4 +430% Jul 1, 2020 Sep 30, 2020
Q2 2020 25 +17.6 +239% Apr 1, 2020 Jun 30, 2020
Q1 2020 31.8 +25.3 +386% Jan 1, 2020 Mar 31, 2020
Q4 2019 33.9 +37.5 Oct 1, 2019 Dec 31, 2019
Q3 2019 5.68 +23 Jul 1, 2019 Sep 30, 2019
Q2 2019 7.37 +34.4 Apr 1, 2019 Jun 30, 2019
Q1 2019 6.54 +51.3 Jan 1, 2019 Mar 31, 2019
Q4 2018 -3.65 +33.4 +90.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -17.3 +26 +60.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -27.1 +8.35 +23.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -44.8 -28.6 -177% Jan 1, 2018 Mar 31, 2018
Q4 2017 -37.1 -24.6 -197% Oct 1, 2017 Dec 31, 2017
Q3 2017 -43.3 -42.4 -4573% Jul 1, 2017 Sep 30, 2017
Q2 2017 -35.4 -35.2 -14519% Apr 1, 2017 Jun 30, 2017
Q1 2017 -16.1 -17.2 -1609% Jan 1, 2017 Mar 31, 2017
Q4 2016 -12.5 -16 -456% Oct 1, 2016 Dec 31, 2016
Q3 2016 -0.93 +0.8 +46.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 -0.24 +2.09 +89.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 1.07 +18.2 Jan 1, 2016 Mar 31, 2016
Q4 2015 3.5 +124 Oct 1, 2015 Dec 31, 2015
Q3 2015 -1.72 Jul 1, 2015 Sep 30, 2015
Q2 2015 -2.33 Apr 1, 2015 Jun 30, 2015
Q1 2015 -17.1 Jan 1, 2015 Mar 31, 2015
Q4 2014 -120 Oct 1, 2014 Dec 31, 2014

Horizon Therapeutics Public Ltd Co Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 10.5 -2.04 -16.3% Jan 1, 2022 Dec 31, 2022
2021 12.5 -0.06 -0.48% Jan 1, 2021 Dec 31, 2021
2020 12.6 -21.3 -62.8% Jan 1, 2020 Dec 31, 2020
2019 33.9 +37.5 Jan 1, 2019 Dec 31, 2019
2018 -3.65 +28.7 +88.7% Jan 1, 2018 Dec 31, 2018
2017 -32.3 -19.8 -159% Jan 1, 2017 Dec 31, 2017
2016 -12.5 -16 -456% Jan 1, 2016 Dec 31, 2016
2015 3.5 +124 Jan 1, 2015 Dec 31, 2015
2014 -120 +220 +64.7% Jan 1, 2014 Dec 31, 2014
2013 -340 -246 -262% Jan 1, 2013 Dec 31, 2013
2012 -93.9 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.